ATE531385T1 - Anti-h5n1-influenza-aktivität des antiviralen proteins cyanovirin - Google Patents

Anti-h5n1-influenza-aktivität des antiviralen proteins cyanovirin

Info

Publication number
ATE531385T1
ATE531385T1 AT07814209T AT07814209T ATE531385T1 AT E531385 T1 ATE531385 T1 AT E531385T1 AT 07814209 T AT07814209 T AT 07814209T AT 07814209 T AT07814209 T AT 07814209T AT E531385 T1 ATE531385 T1 AT E531385T1
Authority
AT
Austria
Prior art keywords
antiviral protein
influenza activity
antiviral
cyanovirin
host
Prior art date
Application number
AT07814209T
Other languages
English (en)
Inventor
Barry R O'keefe
James B Mcmahon
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE531385T1 publication Critical patent/ATE531385T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT07814209T 2006-08-18 2007-08-17 Anti-h5n1-influenza-aktivität des antiviralen proteins cyanovirin ATE531385T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83871206P 2006-08-18 2006-08-18
PCT/US2007/076181 WO2008022303A2 (en) 2006-08-18 2007-08-17 Anti-h5n1 influenza activity of the antiviral protein cyanovirin

Publications (1)

Publication Number Publication Date
ATE531385T1 true ATE531385T1 (de) 2011-11-15

Family

ID=38976570

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07814209T ATE531385T1 (de) 2006-08-18 2007-08-17 Anti-h5n1-influenza-aktivität des antiviralen proteins cyanovirin

Country Status (4)

Country Link
US (1) US20100240578A1 (de)
EP (1) EP2051730B1 (de)
AT (1) ATE531385T1 (de)
WO (1) WO2008022303A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019108656A1 (en) 2017-11-28 2019-06-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Microbicidal composition
EP4499857A1 (de) 2022-03-24 2025-02-05 Danisco US Inc. Zusammensetzungen und verfahren zur herstellung und gewinnung von lektinen im industriellen massstab
EP4590319A1 (de) 2022-09-20 2025-07-30 International N&H Denmark ApS Variante antivirale polypeptide
WO2025007098A1 (en) 2023-06-30 2025-01-02 Danisco Us Inc. Recombinant fungal cells and methods thereof for industrial scale production of lectins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6780847B2 (en) * 1995-04-27 2004-08-24 The United States Of America As Represented By The Department Of Health And Human Services Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
CA2441287C (en) * 2001-03-22 2014-06-10 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
CA2507904C (en) * 2002-12-19 2014-12-02 M. Elizabeth Snell Cyanovirin variant-polymer conjugates
US20060035859A1 (en) * 2003-05-16 2006-02-16 Hemispherx Biopharma Treating severe and acute viral infections

Also Published As

Publication number Publication date
WO2008022303A3 (en) 2008-04-03
US20100240578A1 (en) 2010-09-23
EP2051730B1 (de) 2011-11-02
EP2051730A2 (de) 2009-04-29
WO2008022303A2 (en) 2008-02-21

Similar Documents

Publication Publication Date Title
ES2563646T3 (es) Composiciones y métodos relacionados con variantes de la proteína A (SpA)
BR0211623A (pt) Agentes de contraste alvos multiméricos com base em peptìdeo
NZ600690A (en) Fkbp-l and uses thereof
CY1106334T1 (el) Βελτιστοποιημενου κωδικονιου αλληλουχιες ιου θηλωματος
NO20075927L (no) IL-21 varianter
NZ563845A (en) RNAi sequences against the Influenza A segment 1 PB2 gene and uses thereof as anti-viral therapeutic
EP2455459A3 (de) Lipasevarianten zur pharmazeutischen Verwendung
ATE417595T1 (de) Keratin-bindende polypeptide
MX2009004243A (es) Nuevas proteinas h5, moleculas de acido nucleico y vectores que las codifican y su uso medicinal.
EP1801206A4 (de) Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin
WO2007118206A3 (en) Canine influenza virus
WO2012054907A3 (en) Novel hemagglutinin 5 (h5) proteins for the treatment and prevention of influenza infections
NZ627888A (en) Materials and methods for respiratory disease control in canines
ECSP10010082A (es) Udp-glucuronil transferasa y polinucleotido de codificacion
ATE531385T1 (de) Anti-h5n1-influenza-aktivität des antiviralen proteins cyanovirin
WO2007048086A3 (en) Canine influenza virus and related compositions and methods of use
EP2114431A4 (de) Zusammensetzung mit arazym zur prävention und behandlung von krebs
PL2089433T3 (pl) Terapia ukierunkowana na katepsynę S
ATE490270T1 (de) Zytokinderivate
WO2010057242A3 (de) Vakzin
NO20026147L (no) Trombomodulinanaloger for farmasoytisk anvendelse
WO2008047370A3 (en) Compositions and methods for inducing angiogenesis
WO2011045573A3 (en) Staphylococcal antigens
DK1778271T3 (da) Peptid til behandling af herpesvirusinfektioner
WO2008070049A3 (en) Peptide and treatment for hiv-1 infection